If you need validation that anti - ageing drugs are live to be serious concern , you only have to seem at today ’s purchase of Sirtris , a pharmaceutical fellowship give to researching the anti - ageing benefit of cut back - calorie diets , by GlaxoSmithKline . The price of the purchase ? $ 720 million . And they project to make all of that money back and a whole lot more by trade you pills to make you exist to 120 .
Five years ago , Sirtris Chief Executive and Harvard professor David Sinclair find the molecule resveratrol , which targets the cistron activate by qualified calorie diets and extends lifespans . Now , after enquiry has been done on monkeys and other assorted animals , it ’s nearly time for clinical examination on human race .
The issue of the coming drug wo n’t be to cover your infirm old age so you ’re old and helpless for farseeing . or else , they ’ll slow the aging mental process down all .
And with every major pharmaceutic company currently pour money into researching these genes and drugs , the competition is live to be ferocious once they hit the market . As Sinclair says , ” “ It ’ll be on the market as a diabetes drug . It ’ll have to sell for $ 3 or $ 4 a pill , to stay competitive . And once it goes off - patent , fellowship will be able to make it for pennies . It ’ll be like aspirin . ”
Aspirin that keep you from getting onetime . Welcome to the future , Quaker . It ’s awesome . [ Wired Science ]
DrugsGadgetsScience
Daily Newsletter
Get the best tech , science , and culture news in your inbox daily .
News from the future , rescue to your nowadays .
You May Also Like
